Skip to main content
. 2014 Jul 28;20(28):9286–9291. doi: 10.3748/wjg.v20.i28.9286

Table 1.

National Institutes of Health randomized study: Long-term intraperitoneal 5-fluorouracil can prevent the occurrence of peritoneal metastases n (%)

Sites of treatment failure for IV or IP 5-FU
No. of patients No. of recurrences Peritoneal surface Liver
IP 5-FU 36 13 (36) 2/10 3/11
IV 5-FU 30 11 (37) 10/11 4/11
Statistical analysis P2 0.003 1.000

From ref. [11] with permission. 5-FU: 5-fluorouracil.